NCT06447662 2026-04-20
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Pfizer
Phase 1 Recruiting
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Abramson Cancer Center at Penn Medicine
Phanes Therapeutics
Beijing Chest Hospital, Capital Medical University
Vanderbilt-Ingram Cancer Center
Henan Cancer Hospital